Pfizer Inc PFE:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
49.91quote price arrow down-0.20 (-0.40%)
Volume
925,576
Close
50.11quote price arrow up+1.82 (+3.77%)
Volume
24,802,454
52 week range
40.94 - 61.71
Loading...
  • Open48.55
  • Day High50.39
  • Day Low48.55
  • Prev Close48.29
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low40.94
  • 52 Week Low Date10/13/21

Key Stats

  • Market Cap281.162B
  • Shares Out5.611B
  • 10 Day Average Volume20.20M
  • Dividend1.60
  • Dividend Yield3.19%
  • Beta0.66
  • YTD % Change-15.14

KEY STATS

  • Open48.55
  • Day High50.39
  • Day Low48.55
  • Prev Close48.29
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low40.94
  • 52 Week Low Date10/13/21
  • Market Cap281.162B
  • Shares Out5.611B
  • 10 Day Average Volume20.20M
  • Dividend1.60
  • Dividend Yield3.19%
  • Beta0.66
  • YTD % Change-15.14

RATIOS/PROFITABILITY

  • EPS (TTM)5.19
  • P/E (TTM)9.66
  • Fwd P/E (NTM)8.18
  • EBITDA (TTM)42.238B
  • ROE (TTM)37.84%
  • Revenue (TTM)101.132B
  • Gross Margin (TTM)62.21%
  • Net Margin (TTM)29.44%
  • Debt To Equity (MRQ)46.19%

EVENTS

  • Earnings Date10/31/2022(est)
  • Ex Div Date07/28/2022
  • Div Amount0.40
  • Split Date-
  • Split Factor-

Related Video

VIDEO8:2908:29
Friday, August 12, 2022: Why this sector is strong on falling oil prices

Profile

MORE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of...
Albert Bourla Ph.D.
Chairman of the Board, Chief Executive Officer
David Denton
Executive Vice President, Chief Financial Officer
Aamir Malik
Executive Vice President, Chief Business Innovation Officer
Lidia Fonseca Ph.D.
Executive Vice President, Chief Digital and Technology Officer
Douglas Lankler
Executive Vice President, General Counsel
Address
235 E 42ND ST
New York, NY
10017-5703
United States

Top Peers

SYMBOLLASTCHG%CHG
RHHBY
Roche Holding AG
42.00+0.96+2.34%
ABBV
Abbvie Inc
142.60+0.52+0.37%
MRK
Merck & Co Inc
91.02+2.09+2.35%
JNJ
Johnson & Johnson
165.30-1.84-1.10%
LLY
Eli Lilly and Co
308.08+7.89+2.63%